BioCurex, Inc.(fka BOCX)

[bob1013]

Support is at .48-.50 which is where they are driving the price down.



As for Goldseeker's postings:

1) The technology (RECAF) has not changed. It still detects several types of cancer. It still has more sensitivity and specificity than PSA and other single cancer markers. In other words: IT STILL WORKS!

2) How the company was formed, who founded it etc. may have had significance in 2002-2003...perhaps even also when BOCX was listed on the pink sheets.

It is important to note that BOCX was RECENTLY RELISTED on the OTCBB (Oct 2006). This was not an easy feat. It took a couple years and constant pressure from the company.

I do not believe the company went through the trouble of getting relisted only to give Whittrnberg et al time to pump & dump. If this was the motive they did a piss poor job as BOCX barely scratched the $1 mark (20c move - whoop-dee-doo)

3) BOCX traditionally drifts down to long-term support during periods of little or no news. During these times, instead of giving up patience, questioning the fundamentals of the technology and the integrity of those involved, it is a good time to add to your position and average down. These are rare buying opportunities which only present 1/yr or so